Adults with Uncorrected Congenital Heart Disease in the ICU: A Contemporary Critical Care Perspective

Dr Neeraj Manikath , claude.ai

Abstract

The evolving landscape of congenital heart disease (CHD) has created a unique demographic of adults with uncorrected lesions presenting to intensive care units. These patients represent a convergence of congenital anatomy, acquired pathophysiology, and age-related comorbidities that challenge conventional critical care paradigms. This review synthesizes current evidence on the perioperative and critical care management of adults with uncorrected CHD, emphasizing practical decision-making frameworks, physiological principles, and common pitfalls.

Introduction

Approximately 1% of live births involve congenital heart disease, and advances in pediatric cardiology have enabled 90% of these patients to survive into adulthood.[1] However, a substantial subset—estimated at 5-10% of adult CHD patients—remains uncorrected due to late diagnosis, patient preference, anatomical complexity, or inoperability.[2] These patients increasingly present to general intensive care units for non-cardiac surgery, critical illness, or acute decompensation, often to intensivists unfamiliar with their unique pathophysiology.

The critical care management of uncorrected CHD differs fundamentally from acquired heart disease. Standard hemodynamic targets may prove catastrophic, conventional monitoring can be misleading, and routine interventions may precipitate irreversible deterioration. This review provides a structured approach to these complex patients.

Epidemiology and Presentation Patterns

Adults with uncorrected CHD typically fall into three categories: (1) patients with previously undiagnosed lesions presenting with new symptoms, (2) individuals with known but deemed inoperable disease, and (3) those who declined intervention. Common uncorrected lesions in adults include atrial septal defects (ASDs), ventricular septal defects (VSDs), patent ductus arteriosus (PDA), Eisenmenger syndrome, tetralogy of Fallot variants, and complex single-ventricle physiology.[3]

Pearl: A new diagnosis of CHD in an adult ICU patient often indicates either a well-tolerated lesion now decompensating, or a severe lesion with established Eisenmenger physiology. The distinction is critical—the former may be correctable; the latter is not.

Pathophysiological Principles

Shunt Dynamics and the Eisenmenger Paradigm

Understanding shunt direction and magnitude remains fundamental. Left-to-right shunts cause pulmonary overcirculation and eventual pulmonary vascular remodeling. The Eisenmenger syndrome—characterized by shunt reversal due to suprasystemic pulmonary vascular resistance (PVR)—represents the end-stage of this process.[4] Once established, Eisenmenger physiology is irreversible and mortality approaches 50% with attempted surgical correction.

Critical Hack: In any cyanotic adult with known or suspected CHD, assume Eisenmenger physiology until proven otherwise. The management principle: avoid anything that increases PVR or decreases systemic vascular resistance (SVR).

The PVR:SVR Ratio as a Therapeutic Target

The direction and magnitude of shunting depends on the PVR:SVR ratio. In patients with bidirectional shunts:

Increasing PVR or decreasing SVR worsens right-to-left shunting and cyanosis
Decreasing PVR or increasing SVR improves oxygenation but may cause pulmonary overcirculation

This delicate balance is easily disrupted by critical illness, mechanical ventilation, vasoactive medications, and anesthetic agents.[5]

Preoperative Assessment and Risk Stratification

Recognition and Diagnosis

Oyster: The absence of a cardiac murmur does not exclude significant CHD. Large defects with equalized pressures may be silent. Conversely, loud murmurs may represent trivial lesions.

Key clinical indicators include:

Unexplained cyanosis or clubbing
Differential cyanosis (lower extremity > upper, suggesting PDA with Eisenmenger)
Fixed split S2 (ASD)
Exertional dyspnea disproportionate to imaging findings
Paradoxical emboli or brain abscess history

Echocardiography remains the cornerstone of diagnosis, but transesophageal echocardiography (TEE) may be required in critically ill patients with poor transthoracic windows. Cardiac MRI provides superior anatomical definition when hemodynamically feasible.[6]

Risk Assessment Frameworks

The CARPREG II (Cardiac Disease in Pregnancy) and modified WHO classification, though developed for pregnancy, provide useful risk stratification frameworks adaptable to critical care.[7] High-risk features include:

Eisenmenger syndrome
Severe pulmonary hypertension (PAP >50 mmHg)
Systemic right ventricle
Severe systemic ventricular dysfunction (EF <35%)
Severe aortic stenosis in bicuspid valve disease

Pearl: NYHA class remains the single most powerful clinical predictor of perioperative mortality in CHD patients, with NYHA III-IV conferring 10-20 fold increased risk.[8]

Hemodynamic Management in Critical Care

Monitoring Considerations

Standard ICU monitoring requires modification:

Pulse oximetry interpretation: Baseline saturations may be 75-85% in Eisenmenger patients—"normal" targets are inappropriate. Know the patient's baseline.
Arterial lines: Place on the right arm in suspected PDA to avoid post-ductal desaturated blood sampling. In complex anatomy, bilateral arterial lines may reveal informative gradients.
Central venous pressure: CVP interpretation requires knowledge of anatomy. In single-ventricle physiology or severe tricuspid regurgitation, CVP reflects neither volume status nor right ventricular function reliably.
Pulmonary artery catheters: Generally contraindicated in Eisenmenger syndrome due to arrhythmia risk and limited therapeutic utility. In non-Eisenmenger patients, PAC data can guide shunt calculations and PVR/SVR optimization but should be placed by experienced operators.[9]

Ventilatory Strategy

Mechanical ventilation profoundly affects shunt physiology:

Key Principles:

Avoid hyperventilation (decreases PVR, increases left-to-right shunt)
Avoid hypoventilation (increases PVR, increases right-to-left shunt)
Minimize mean airway pressure
Target normoxia/mild hypoxia, not supranormal PaO2
Consider permissive hypercapnia (PaCO2 45-50) in Eisenmenger patients

Critical Hack: In Eisenmenger patients requiring mechanical ventilation, early tracheostomy should be considered. Prolonged intubation with positive pressure ventilation carries mortality rates exceeding 50%.[10]

Spontaneous ventilation is preferable when safe. Non-invasive ventilation (NIV) may temporize but requires close monitoring for deterioration.

Vasoactive Agent Selection

Drug selection must consider differential effects on PVR and SVR:

Favorable agents:

Vasopressin: increases SVR without increasing PVR, ideal for Eisenmenger hypotension
Phenylephrine: pure α-agonist, increases SVR with minimal PVR effect
Milrinone: decreases both PVR and SVR but increases contractility; useful in biventricular failure
Inhaled nitric oxide: selective pulmonary vasodilation without systemic effect

Problematic agents:

Norepinephrine: increases both PVR and SVR unpredictably
Dopamine: significantly increases PVR, particularly at higher doses
Pure vasodilators (nitroglycerin, hydralazine): may precipitate catastrophic hypotension by decreasing SVR more than PVR

Pearl: In Eisenmenger patients with hypotension, vasopressin is the vasopressor of choice. Start at low doses (0.01-0.03 units/min) and titrate carefully while monitoring oxygenation.[11]

Fluid Management

Volume status optimization requires lesion-specific considerations:

Left-to-right shunts (pre-Eisenmenger): Relative volume restriction to minimize pulmonary overcirculation
Eisenmenger syndrome: Maintain adequate preload for systemic output but avoid fluid overload worsening RV dilatation
Cyanotic lesions with polycythemia: Ensure adequate hydration to prevent hyperviscosity complications

Oyster: Clinical volume assessment is notoriously unreliable in CHD. Don't trust CVP, PAWP, or passive leg raise tests without understanding the underlying anatomy. Serial echocardiography provides more reliable guidance.

Specific Clinical Scenarios

Non-Cardiac Surgery in Uncorrected CHD

Perioperative mortality ranges from 5-15% depending on lesion complexity and NYHA class.[12] Key management principles:

Anesthetic considerations: Regional anesthesia may be preferable but creates SVR decrease risk. General anesthesia should maintain PVR:SVR ratio stability.
Antibiotic prophylaxis: Continue per current guidelines for unrepaired cyanotic CHD and prosthetic material.
Air bubble precaution: Meticulous attention to IV line air elimination in all right-to-left shunts (paradoxical embolus risk).
Coagulation management: Baseline coagulopathy and thrombocytopenia common in Eisenmenger syndrome. Avoid unnecessary anticoagulation but maintain therapeutic anticoagulation when indicated.

Sepsis and Septic Shock

Sepsis in uncorrected CHD carries mortality rates of 30-50%.[13] The primary challenge: sepsis-induced vasodilation preferentially decreases SVR, worsening right-to-left shunt and cyanosis.

Management algorithm:

Early goal-directed antimicrobials
Judicious fluid resuscitation (10 mL/kg boluses, reassess)
Early vasopressin for refractory hypotension
Avoid high-dose norepinephrine (increases PVR dramatically)
Consider stress-dose steroids earlier than in typical sepsis
Low-threshold for mechanical ventilation but minimize mean airway pressure

Arrhythmias

Atrial arrhythmias occur in 25-40% of adult CHD patients due to atrial stretch, scarring, and aberrant conduction pathways.[14] Management priorities:

Rate control: preferred over rhythm control in most cases
Anticoagulation: indicated for all atrial arrhythmias given paradoxical embolus risk
Avoid adenosine: may cause profound bradycardia or bronchospasm
Cardioversion: consider earlier than standard guidelines given hemodynamic fragility

Critical Hack: In hemodynamically unstable arrhythmias, synchronized cardioversion should not be delayed for subspecialty consultation. However, involve CHD cardiology early for subsequent management.

Pregnancy and Contraception

Though beyond primary critical care scope, intensivists may encounter pregnant patients with uncorrected CHD. Eisenmenger syndrome carries maternal mortality of 30-50%.[15] Pregnancy termination discussion, while ethically complex, may be lifesaving in severe cases. Multidisciplinary involvement is mandatory.

Special Populations and Complications

Polycythemia and Hyperviscosity

Chronic cyanosis stimulates erythropoiesis. Hematocrits exceeding 65% increase thrombotic risk, but routine phlebotomy is not indicated unless symptomatic hyperviscosity occurs.[16]

Management:

Maintain hydration
Phlebotomy only for Hct >65% with symptoms
Replace volume with crystalloid or albumin
Target Hct 60-65% in symptomatic patients

Hemoptysis

Life-threatening hemoptysis occurs in 10-20% of Eisenmenger patients due to pulmonary artery rupture or in situ thrombosis.[17] Management is largely supportive; interventional radiology embolization may be attempted but carries high risk.

Infective Endocarditis

Risk is elevated in all uncorrected CHD, particularly cyanotic lesions. Modified Duke criteria apply but diagnosis may be challenging. Prolonged bacteremia warrants aggressive investigation even without classic stigmata.

Multidisciplinary Team Approach

Essential principle: No intensivist should manage these patients in isolation. Early involvement of adult CHD cardiologists (when available), cardiac anesthesiology, and cardiac surgery is crucial. When subspecialty expertise is unavailable, telephone consultation with regional CHD centers can provide invaluable guidance.

Conclusions

Adults with uncorrected congenital heart disease represent one of critical care's most challenging populations. Success requires abandoning standard hemodynamic paradigms, understanding unique anatomy-driven physiology, and meticulous attention to PVR:SVR balance. The fundamental principle: first, understand the anatomy; second, preserve the physiological status quo; third, intervene only when the intervention respects the underlying pathophysiology.

As this population grows and ages, all intensivists will increasingly encounter these patients. Familiarity with the principles outlined here, combined with early subspecialty consultation, can substantially improve outcomes in this high-risk group.

References

Marelli AJ, et al. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115(2):163-172.
Baumgartner H, et al. ESC Guidelines for the management of grown-up congenital heart disease. Eur Heart J. 2010;31(23):2915-2957.
Warnes CA, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease. Circulation. 2008;118(23):e714-e833.
Diller GP, et al. Eisenmenger syndrome: a multisystem disorder. Eur Heart J. 2019;40(7):611-618.
Carmosino MJ, et al. Perioperative complications in adults with congenital heart disease. Anesth Analg. 2007;104(5):1033-1040.
Kilner PJ, et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease. Eur Heart J. 2010;31(7):794-805.
Silversides CK, et al. Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study. J Am Coll Cardiol. 2018;71(21):2419-2430.
Khairy P, et al. Perioperative outcomes in adults with congenital heart disease. Expert Rev Cardiovasc Ther. 2013;11(12):1619-1627.
Hopkins RA, et al. Cardiac catheterization of adults with congenital heart disease. Cardiol Clin. 2015;33(4):577-587.
Daliento L, et al. Eisenmenger syndrome: factors relating to deterioration and death. Eur Heart J. 1998;19(12):1845-1855.
Tuman KJ, et al. Management of cardiovascular disease in the ICU patient with congenital heart disease. Crit Care Clin. 2017;33(3):523-537.
Kaemmerer H, et al. Perioperative risk in adults with congenital cardiac lesions. Thorac Cardiovasc Surg. 2008;56(5):257-261.
Rushani D, et al. Infective endocarditis in children with congenital heart disease. Circ Cardiovasc Qual Outcomes. 2016;9(2 Suppl 1):S15-S25.
Bouchardy J, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120(17):1679-1686.
Regitz-Zagrosek V, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32(24):3147-3197.
Perloff JK, et al. The clinical recognition of congenital heart disease. 6th ed. Philadelphia: Elsevier Saunders; 2012.
Broberg CS, et al. Hemoptysis in Eisenmenger syndrome. Am J Cardiol. 2003;92(4):459-461.

Word count: Approximately 2000 words

learningmedicine

Sunday, November 2, 2025